HealthTrackRx’s Post

A call for precision and objectivity in clinical care, particularly in biomarker discovery and recovery for active and aging patient populations. Too often, we capture patient-specific data only after significant functional deterioration. Without prior baseline measures or benchmark data, this information lacks the necessary impact. Every clinical setting, both traditional and digital, should prioritize objective measures and have the tools to consistently collect stable biomarkers, such as grip strength and gait, to improve patient outcomes. #ClinicalCare #Biomarkers #PatientOutcomes #DigitalHealth #ObjectiveData #HealthcareInnovation #AgingPopulation #PrecisionMedicine

This proof-of-concept observational study shows that dd-cfDNA, a noninvasive biomarker for rejection risk, can be used to help inform physician decisions regarding IST reduction in KTx patients, along with patient evaluation and other clinical factors. #OpenAccess tinyurl.com/45s8sr9z

NICE - National Institute for Health and Care Excellence Institute for Health and Care Excellence Forward View 2024-2025 NICE has released their forward view for 2024-2025, outlining the key priority areas that will guide their efforts in the coming year. Their goal is to ensure that patients receive the most effective treatments promptly, while also delivering value to the taxpayer. These priorities are set to be reviewed and refreshed annually to stay responsive to significant developments and innovations in life sciences, health, and care. NICE’s Priority Areas: 🔹 Mental Health 🔹 Early Cancer Detection/Diagnosis 🔹 Diabetes 🔹 Musculoskeletal Conditions 🔹 Women’s Health 🔹 Respiratory 🔹 Neurology NICE’s horizon scanning function is actively evaluating emerging trends in health and care. Over the next 2-5 years, they anticipate reviewing new innovations in underserved clinical areas and exploring evolving delivery models to enhance existing treatments. They are particularly focused on new pharmacological treatments, advanced therapy medicinal products, and personalized medicine driven by high-throughput sequencing and AI. Do you need support to be compliant with the #UK, #European or #Swiss regulatory requirements for medical devices or #IVDs ? Reach out to us ☞ meetus@taoexcellence.ch #HealthcareExcellence #NICEGuidelines #HealthInnovation #StrategicPriorities #LifeSciences #FutureOfHealthCare #medtech #regulatoryaffairs #regulatorycompliance #invitrodiagnostics #clinicalaffairs #artificialintelligence #AI #publichealth #patientcare #healthtech

Exciting developments in #healthcare technology are reshaping the landscape of diagnostics! The #Coagulation Analyzer Market is witnessing unprecedented growth driven by advancements in precision medicine and patient-centric care. Stay informed about the latest #trends, innovations, and opportunities in this rapidly evolving sector. Get more information visit here: https://lnkd.in/dyVuvCBr #HealthcareTech #Diagnostics #CoagulationAnalyzer #Innovation #researchreport #marketresearch

📘 Download the AL amyloidosis patient guide. Did you know that 10–15% of myeloma patients develop amyloidosis and around 30% have subclinical amyloid deposits? You can learn more about AL amyloidosis with this MPE patient guide. It answers questions like: ❓ How can AL amyloidosis affect me? ❓ What treatments are available? ❓ How will it impact my quality of life? 👉 Download now: https://lnkd.in/d2XndWE5 #ALAmyloidosis #myeloma #PatientSupport #MPEducation

🧬 Discover at INASL 2024 from August 7-10 to explore our poster presentation titled "One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population" using the OWLiver test. This innovative approach aims to improve the accuracy and ease of diagnosing these conditions, offering significant benefits for patient care and management. Our test demonstrates high sensitivity (86.1%) and positive predictive value (85.3%) for detecting MASH. The OWLiver Panel shows reliable accuracy in identifying MASH and significant fibrosis among high-risk individuals. This advancement in non-invasive diagnostics can revolutionize how we approach liver health and patient care.🔬 🗣️ Don't miss this opportunity to learn more about how our work can impact liver health and the future of medical diagnostics during the oral presentation of the poster on the Session - Special Interest Group (SIG) – MASLD the 9th August from 8:00 AM – 8.50 AM in Hall – 1. #INASL2024 #LiverHealth #Metabolomics #MedicalInnovation #Healthcare

How do you tackle a backlog of cancer patients waiting months for treatment? One of the key strategies this healthcare team used was organizing patient care into 'product families': 🩺 New Patients 💉 Patients Coming for Treatment 🚑 Urgent Care Patients 🔄 Follow-Up Patients Within these groups, they further categorized chemotherapy by session length (short, medium, long) and type of drug (oral or IV). This precise segmentation enabled the team to create productive, patient-centered workflows. By using lean techniques and processes, they were able to cut wait times for new patients from months to weeks, reduce door-to-door time for oral drug pickup from 50 minutes to 12 minutes, and open 15% more treatment slots with the same team. Learn how lean techniques improved care for hundreds of patients: https://hubs.li/Q02_-qQ_0 #Healthcare #LeanThinking #ContinuousImprovement

Did you know that chronic diseases account for a whopping 84% of deaths globally? That's a staggering number. Digital therapeutics (DTx) are transforming the way we treat chronic conditions. These aren't just apps; they're evidence-based treatments delivered right to your smartphone for personalized care, improved engagement, and better outcomes for chronic conditions like diabetes, hypertension, and mental health. Read the article to learn more! Innovation & Tech Today American Medical Association American Hospital Association Digital Health Insights Becker's Healthcare BioSpace McKinsey & Company FDA Manisha Khadge Pravin Uttarwar #digitaltherapeutics #personalizedmedicine #healthcare #wellness #healthtech #futureofhealthcare

India's diagnostic sector is vital for disease detection, treatment planning, and patient monitoring. Driven by a large population, rising disease burden, and a shift toward preventive care, it plays a key role in improving health outcomes. This article examines its current status, challenges, and future prospects.More... Dr Lalpath Labs, Agilus Diagnostics,Metropolis Healthcare,Thyrocare Technologies Ltd. Ameera Shah, https://lnkd.in/ggef2yJK

Just Released: The EANO Guideline on molecular testing of meningiomas for targeted therapy selection! Evidence-based guidance for patient care & clinical trials, and show of areas for which additional research is warranted. Learn more: https://lnkd.in/e7NgkWM2 #EANO #EANOguideline #Meningioma #TargetedTherapy #ICOM